A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models.
Tay AHM, Prieto-Díaz R, Neo S, Tong L, Chen X, Carannante V, Önfelt B, Hartman J, Haglund F, Majellaro M, Azuaje J, Garcia-Mera X, Brea JM, Loza MI, Jespers W, Gutierrez-de-Teran H, Sotelo E, Lundqvist A.
Tay AHM, et al. Among authors: sotelo e.
J Immunother Cancer. 2022 May;10(5):e004592. doi: 10.1136/jitc-2022-004592.
J Immunother Cancer. 2022.
PMID: 35580926
Free PMC article.